Talon Pharma

www.talonpharma.com
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Proof of Concept
Fund:
Prospects
Cell Permeable KV1.3 Antagonists: Novel Targeting of Apoptosis in Cancer Treatment

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.